ArticleJournal of pharmacy & bioallied sciences2023
Molecular Docking Study of New Sorafenib Analogues as Platelet-Derived Growth Factor Receptor Inhibitors for the Treatment of Cancer.
Marwan I Jihad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.